Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Development and commercialization of therapeutics for the treatment of metabolic dysfunction2M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States2M100.00%